PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,396 stories, page 26 of 807

Advanced search
🇯🇵Industrysanten.comTier 1 · Company source

近視の進行抑制を目的とする点眼剤STN1012700（Ryjusea 0.25mg/mL点眼液）の販売承認を韓国で取得

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

一部製品の価格改定に関するご案内

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

統合報告書「Santen Report 2026」を発行

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

Advanced Vision Science社の譲渡について

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

近視の進行抑制を目的とする点眼剤STN1012700（アトロピン硫酸塩点眼液0.025％）の中国における承認申請が受理

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

緑内障・高眼圧症治療剤「ロープレッサ®点眼液0.02%」発売のお知らせ

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

世界初開催の「Global Summit for Eye Health」にHigh Impact Partnerとして参画

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

アレルギー性結膜炎治療剤「アレジオン®眼瞼クリーム0.5%」参天製薬と杏林製薬の日本における共同販売促進契約締結のお知らせ

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

近視の進行抑制を目的とする点眼剤STN1012700（Ryjusea 0.25mg/mL点眼液）についてアジア事業地域で初めてとなる販売承認をフィリピンで取得

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

緑内障・高眼圧症治療剤「ロープレッサ®点眼液0.02%」国内における製造販売承認を取得

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

「ちびまる子ちゃん」と考える、子どもの近視 ― 日常の気づきから“まずは眼科へ”を伝える疾患啓発メッセージを全国に展開 ―

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

Santen中国、5つの緑内障点眼薬について、中国本土における独占的な流通および販売促進に関する契約を締結

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

後天性眼瞼下垂治療剤「アップニーク®ミニ点眼液0.1%」発売のお知らせ

Santen Pharmaceutical NewsOriginal source
🇯🇵Industrysanten.comTier 1 · Company source

役員人事に関するお知らせ

Santen Pharmaceutical NewsOriginal source
🇺🇸Researchonlinejcf.comTier 2 · Direct publisher

Updated Staging System to Define Cardiogenic Shock Severity A Cardiogenic Shock Working Group Report

Journal of Cardiac FailureOriginal source
🇯🇵Industrykifu-shinsei.jpTier 3 · Secondary coverage

「2026年度 参天製薬奨学寄付プログラム」の募集は終了しました

Santen Pharmaceutical NewsOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Stem cell therapies for chronic obstructive pulmonary disease: mapping the global clinical trial landscape

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Cefepime Dose Individualization in Early Sepsis: A Pragmatic Feasibility Trial Protocol

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

GenMAS: A Machine Learning-Based Modeling and Assessment Strategy for ADMET Profiling and its Application in PBPK Simulation.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

An Efficient Workflow to Access Cocrystal Eutectics across a Wide Solubility Range and Evaluate Determinants of Cocrystal Solubility.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

AI-Assisted Analysis of Clinical Trials to Identify Failed Drugs for Revival via Drug Delivery Technologies.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Welcoming Novelty in the Treatment of Coronary Artery Disease: FDA Approves the Use of Drug-Coated Balloon for Angioplasty.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Estimands for Randomized Discontinuation Designs in Oncology.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Practical Considerations for the Design, Conduct, and Reporting of Clinical Pharmacokinetic Drug-Drug Interaction Studies in Drug Development.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Severe Infection Outcomes With SGLT2 Versus DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Active-Comparator Meta-Analysis of Real-World Cohorts.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Drug Discovery for Snakebite Envenoming: Wanderings Amid Historical Antidotes and Emerging Therapeutic Opportunities.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Janus Kinase Inhibitor Use Among People With Inflammatory Disease in Australia.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Estimation Following Surrogate Based Selection in Multi-Arm Drop-The-Losers Designs.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Response to correspondence on 'Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity (SORAIRO trial)'.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Liquid Compared to Solid Oral Formulations of the Thyroid Hormone Receptor Agonist Elunetirom Under Fasted and Fed Conditions in Healthy Participants.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Semaglutide and Panic Attacks: Active-Comparator Disproportionality Analysis, Temporal Assessment of Notoriety Bias and Evidence Triangulation in Post-Marketing Pharmacovigilance.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Estimation of Treatment Effect in Clinical Trials of Continuous Endpoints With Retrieved Dropouts.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Rare and Novel Hepatitis C Virus Genotype Subtypes and Response to Sofosbuvir/Velpatasvir in A5360 (MINMON) Clinical Trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Stereoselective Determination of Omeprazole and 5-Hydroxy-Omeprazole in Dried Blood Spots for CYP2C19 Activity Assessment.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Unified Implementation and Comparison of Bayesian Shrinkage Methods for Treatment Effect Estimation in Subgroups.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Landscape Analysis of Digital Health Technology Use for Remote Data Acquisition in CDER-Regulated Submissions, 2023-2025.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population With Obesity: An Open Randomized Controlled Feasibility Study (TAZO-OBESITY Trial).

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Target Trial Emulation or Target Trial Approximation?

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Variations of Power Priors in Time-to-Event Analysis With Piecewise Constant Hazards Through Baseline and Outcome Similarity Driven Bounded Weighting.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Power With Confounders in Clinical Trials Using External Controls.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Effects of SGLT-2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine-N-Oxide in Patients With Type-2 Diabetes.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Global Landscape and Thematic Evolution of Selective GLP-1 Receptor Agonists and GLP-1-Based Multi-Receptor Agonists in Type 2 Diabetes Mellitus: A Bibliometric Analysis.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

TITE-LOCRM12: A Local Continual Reassessment Method for Drug Combination Optimization Based on Late-Onset Toxicity and Efficacy Outcomes.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

BEACON: An Adaptive Bayesian Early-Phase Oncology Trial Design Integrating Dose Optimization and Proof-of-Concept Across Survival and Binary Endpoints.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

A Seamless Phase I/II Design With Randomization for Biomarker-Guided Oncology Trials.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Forced Degradation Study of Vonoprazan Fumarate by HPLC and Characterisation of Its Degradation Products Using LC-QTOF-MS/MS.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Targeting the TL1A pathway in inflammatory bowel disease: mechanistic insights and emerging therapeutic pipeline.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

A Phase I First-Time-in-Human, Open-label Study of Nelistotug Administered to Patients with Advanced Solid Tumors.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

EMB-01, an Anti-EGFR/c-MET Bispecific Antibody, in Patients with Heavily Pretreated Metastatic Colorectal Cancer from a Phase Ib/II, Open-Label, Multicenter Study.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

<b>A clinical study on the efficacy of rectal administration of Tongfu Qinghua decoction combined with external application of Ruyi Jinhuang powder in treating acute pancreatitis</b>.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Danvatirsen plus Pembrolizumab versus Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma (PEMDA-HN): A Randomized, Phase II Trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor against Uncommon EGFR Mutations.

Europe PMCOriginal source
🌍Researchdoi.orgTier 1 · Research record

First-trimester Detection of Isolated Unilateral Complete Radial Aplasia during Nuchal Translucency Screening: A Case Report

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Sleep apnea–hypopnea in children: Evidence that Lize Tongqi decoction with acupuncture, moxibustion, and Xinwu acupoint stimulation is superior to standard Western treatment using montelucast/mometasone furoate

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Pharmacotherapy of heart failure: Impact of the 2021 guideline update on guideline-directed medical therapy assessed using a Japanese employee health insurance claims database

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Mechanistic Insights and Therapeutic Potential of MCC950 as a NLRP3 Inflammasome Inhibitor in Multiple Sclerosis: A Narrative Review

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Occupational Hazards Faced by Nursing Students in Clinical Training Settings

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Are there differences in depression across biological sex and developmental phases? Examining the structure and measurement invariance of depressive symptoms in males and females from childhood through adolescence.

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Lessons from the TRIPLET-HCC trial – Authors’ reply

CrossrefOriginal source